Int Conf AIDS. 1993 Jun 6-11;9(1):377 (abstract no. PO-B10-1452). Unique
Pancreatic side effects have been described with Pentamidine curative
treatment for pneumocystis carinii pneumonia (PCP). We assessed the
pancreatic beta-cells functions of HIV-patients receiving either 300
mg/month aerosolized Pentamidine (n = 12) or oral
trimethoprime-sulfamethoxazole (TMP:160 mg, SM:800 mg twice a day three
times/week, n = 10). All fully informed patients were in CDC stage III
or IV. Intra-veinous glucose tolerance tests were performed: after IV
injection of 0.5 g/kg BW glucose in 30 seconds, plasma insulin levels
were assessed at baseline, 3 and 5 mn. Moreover, in patients receiving
inhaled Pentamidine, plasma glucose, amylase and insulin levels were
measured every 30 mn for 2 hours after the beginning of the aerosol
therapy. Plasma Pentamidine levels were measured 30 mn after the end of
the aerosol treatment. Those tests were performed every 2-3 months for
one year. In all patients, pentamidine levels were detectable, but under
toxic levels (50 ng/ml). Pentamidine plasma levels increased in a
time-dependant manner: 1.8 ng/ml at 3 month, 2.5 at 6 month, 4.7 at 9
month, 5.7 at 12 month, 8.1 at 18 month, 8.4 after 18 months. Baseline
plasma glucose, amylase and insulin levels were normal, and remain
stable during the treatment. For 8/12 patients, glucose tolerance tests
showed a adequate insulin secretion: the addition of insulin levels at 3
and 5 mn were higher than 70 IU/ml. When this criteria was not found (n
= 4), a glucagon stimulation test allowed to exclude a endocrine
pancreatic dysfunction. Because of a short half-life, increased
pentamidine levels are probably related to an improvement of spray
techniques rather than a cumulative effect. Pancreatic functions were
preserved in pentamidine-treated patients compared to TMP-SM-treated
patients. In conclusion, in this 12 month study, our results suggest the
absence of side effects in preventive nebulised pentamidine treatment on
endocrine pancreatic function.
*AIDS-Related Opportunistic Infections/PREVENTION & CONTROL
*Insulin/BLOOD *Islets of Langerhans/DRUG EFFECTS *Pentamidine/ADVERSE
EFFECTS *Pneumonia, Pneumocystis carinii/PREVENTION & CONTROL
www.aegis.org